Insight Pharmaceuticals, A Prestige Consumer Healthcare Inc. Company, Issues Voluntary Nationwide Recall Of Americaine 20% Benzocaine Topical Anesthetic Spray Due To The Presence Of Benzene
Portfolio Pulse from Benzinga Newsdesk
Insight Pharmaceuticals, a subsidiary of Prestige Consumer Healthcare Inc., is voluntarily recalling one lot of Americaine 20% Benzocaine Topical Anesthetic Spray due to the detection of benzene, a known carcinogen, from the propellant in the product. The recall is limited to one lot, with no other lots affected. The company has not received any reports of serious adverse events and is offering refunds to consumers with the affected lot. The recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
December 22, 2023 | 2:03 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Prestige Consumer Healthcare Inc. is recalling one lot of Americaine 20% Benzocaine Spray due to benzene contamination. The recall is limited and no serious adverse events have been reported. The company is offering refunds and has informed the FDA.
The recall of a product due to a carcinogenic contaminant is negative news that could potentially harm the company's reputation and lead to financial costs associated with the recall and refunds. However, the impact may be mitigated by the fact that it is a single lot recall and there have been no serious adverse events reported.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 80